Navigation Links
Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Date:8/21/2007

e product may qualify for seven years of marketing exclusivity in the United States.

MGCD0103 is an orally-administered, isotype-selective HDAC inhibitor. The compound is currently in two Phase I/II clinical trials, in combination with Vidaza(R) for hematological malignancies and with Gemzar(R) in solid tumors, and in four Phase II monotherapy clinical trials in hematological malignancies.

About Hodgkin's Lymphoma

Hodgkin's lymphoma (HL) is a cancer of the lymphatic system that begins in the lymph nodes and progresses to other organs, including the lungs, liver, bone and bone marrow. It is characterized by the presence of Reed-Sternberg cells. Currently, there is no known cause of the disease, but epigenetic alterations, including histone acetylation, have been identified. In addition, the Epstein-Barr virus, HIV and familial history are known risk factors. The disease is slightly more prevalent in men than women, and the median age of diagnosis is 38.

About Pharmion

Pharmion is a leading global oncology company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

About MethylGene

MethylGene Inc. (TSX: MYG) is a publicly-traded biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer. The Company's lead product, MGCD0103, is an oral isotype-selective HDAC inhibitor presently in multiple clinical trials for solid tumors and hematological malignancies, including Phase II monotherapy and Phase I/II combination trials with Vidaza(R) and Gemzar(R)
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...he Prox1 gene is a two-way switch that, if turned ...ogrammed so that they lose their identity and beco...MPHIS, Tenn., Dec. 1 S... have discovered that a certain differentiated cel...requires the constant expression of a gene called ...
(Date:12/1/2008)...eduled for Tuesday, December 9 at 11:00 am ET to D... SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire...aq: SNSS ), a biopharmaceutical company focused ...cology therapeutics, today announced new data from...a (AML) will be presented during the 50th American...
(Date:11/30/2008)...swire-USNewswire/ -- Abnormalities in auditory and...with autism spectrum disorder by using magnetoence...today at the annual meeting of the Radiological So...EG, we can record the tiny magnetic fields associa...Roberts, Ph.D., vice chair of research in the Depa...
(Date:11/26/2008)... 26 Children whose eyes...ntly increased risk of developing mental illness b...o Clinic study published this month in Pediatrics ...Pediatrics. , , The retrospective study exa...abismus (misaligned eyes) and compared them with r...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Eye Divergence in Children Triples Risk of Mental Illness 2Oncolytics Biotech Inc Announces Issuance of 26th U S Patent 4033 1Oncolytics Biotech Inc Announces Issuance of 26th U S Patent 4033 2TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 1TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 2Misys and Allscripts Create a Leader in Healthcare Software 4027 1Rwanda conservation effort to link isolated chimps to distant forest 2534 1Rwanda conservation effort to link isolated chimps to distant forest 2534 2Rwanda conservation effort to link isolated chimps to distant forest 2534 3
(Date:12/1/2008)...y prevent cognitive decline in some, study says ,...der adults who exercise regularly have increased b...n, a new study shows. , The University of North...nday at the Radiological Society of North America ...n other studies that exercise prevents cognitive d...
(Date:12/1/2008)...stress disorder (PTSD) affects as many as one in f...ience like rape, assault, war or terrorism. It has...n up survivors, families. , There is no broadly...eveloping the disorder, but thanks to a Tel Aviv U...g PTSD may be just around the corner. , Prof. Jo...
(Date:12/1/2008)...ec. 1 Medication therapy managemen...omplished professionals to its,advisory board. ,...nclude Martin Makary, M.D.;,Michael Burcham; and ...f,advisors that has helped PharmMD launch and hon...edication error, misuse, overuse and abuse. MTM i...
(Date:12/1/2008)...Newswire-USNewswire/ -- Condell Health Network, pa...bed hospital in Libertyville - after voluntarily d...edicaid payments - has agreed without litigation t...36 million as a result of filing false claims for ...S. Attorney for the Northern District of Illinois....
Breaking Medicine News(10 mins):Health News:Easing the stress of trauma 2Health News:PharmMD Expands Advisory Board 2Health News:Condell Health Network and Medical Center to Pay $36 Million Settlement After Self-Reporting Possible Health-Care Fraud 2
...ld observes Women's Day to celebrate the emancipat...a special reason to rejoice//. In addition to the ...ditional laurel of becoming Nepal's only graduate ...four, Rashmila, now 24, was worshipped and revered...
...a expecting at least 100,000 medical tourists in t...try is in the pink of its health//. Foreigners ar...nd cosmetic surgery, facial surgery, dental treatm...ee replacement, ophthalmology, voice therapy and o...
...e materials that grab stem cells and spur their gr...ries. Linda Griffith and her colleagues// at MIT h... could help cells survive the harsh transplant env.... Scientists are now testing the material in anima...
...ade long study has come out in support of the adag...h. Dutch researchers examined around 1500 men// wh...hey have concluded that while drinking less than a...r rates of death from cardiovascular causes and ot...
Other Medicine News:Health News:Nepal Gets Its First Graduate Goddess 2Health News:Kerala Sees Medical Tourism Soaring 2Health News:Healing Bone With Stem Cells 2
For the quantitative in vitro determination of Sodium in serum and plasma.
Enzymatic assay for the quantitative in vitro determination of glycated protein (fructosamine) in human serum or plasma.
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma
Medicine Products: